The diversity of the receptors on our immune cells that recognize 'foreign' material is ensured by combining a set of gene segments to form the final receptor genes. A crucial player in that process has now been found.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026
British Journal of Cancer Open Access 25 October 2005
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Moshous, D. et al. Cell 105, 177–186 (2001).
Ma, Y., Pannicke, U., Schwarz, K. & Lieber, M. R. Cell 108, 781–794 (2002).
Fugmann, S. D., Lee, A. I., Shockett, P. E., Villey, I. J. & Schatz, D. G. Annu. Rev. Immunol. 18, 495–527 (2000).
Grawunder, U. & Harfst, E. Curr. Opin. Immunol. 13, 186–194 (2001).
Bosma, M. J. & Carroll, A. M. Annu. Rev. Immunol. 9, 323–344 (1991).
Roth, D. B. et al. Cell 70, 983–991 (1992).
Lieber, M. R. et al. Cell 55, 7–16 (1988).
Nicolas, N. et al. J. Exp. Med. 188, 627–634 (1998).
Besmer, E. et al. Mol. Cell 2, 817–828 (1998).
Shockett, P. E. & Schatz, D. G. Mol. Cell. Biol. 19, 4159–4166 (1999).
Paull, T. T. & Gellert, M. Genes Dev. 13, 1276–1288 (1999).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fugmann, S. Breaking the seal. Nature 416, 691–693 (2002). https://doi.org/10.1038/416691a
Issue Date:
DOI: https://doi.org/10.1038/416691a
This article is cited by
-
Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026
British Journal of Cancer (2005)
